SCHEMBL6200236

SCHEMBL6200236

O=C1NCCNc2c(I)cc(F)cc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP10 Q53GL7 10/20 0.45
▸ PARP1 P09874 9/20 0.45
▸ FABP6 P51161 1/20 0.41
▸ TGM2 P21980 1/20 0.37
▸ PARP11 Q9NR21 4/20 0.35
▸ GRM5 P41594 2/20 0.35
▸ PARP2 Q9UGN5 2/20 0.34
▸ DYRK3 O43781 1/20 0.34
▸ TNKS O95271 1/20 0.34
▸ PGR P06401 1/20 0.34
▸ CDK1 P06493 1/20 0.34
▸ ADRB1 P08588 1/20 0.34
▸ POLA1 P09884 1/20 0.34
▸ PIM1 P11309 1/20 0.34
▸ SLC6A2 P23975 1/20 0.34
▸ ADRA1A P35348 1/20 0.34
▸ PTGS2 P35354 1/20 0.34
▸ CDK16 Q00536 1/20 0.34
▸ PDE4D Q08499 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6200381 0.81 MEN1 (0.47) PARP10PARP1FABP6TGM2PARP11
SCHEMBL31297470 0.79 PARP10 (0.45) PARP10PARP1FABP6TGM2PARP11
SCHEMBL6203539 0.75 PARP10 (0.41) PARP10PARP1FABP6TGM2PARP11
SCHEMBL6200228 0.73 PARP10 (0.41) PARP10PARP1FABP6TGM2PARP11
SCHEMBL6198768 0.70 PARP1 (0.46) PARP10PARP1PARP11PIM1DYRK1A
SCHEMBL6198730 0.69 FABP6 (0.38) PARP10PARP1FABP6TGM2PARP11
SCHEMBL16593595 0.68 PARP10 (0.37) PARP10PARP1PARP11GRM5
SCHEMBL26465594 0.64 TGM2 (0.40) PARP1TGM2GRM5CDK2
SCHEMBL23951998 0.63 PARP10 (0.56) PARP10PARP1FABP6PARP11GRM5
SCHEMBL32669251 0.63 PARP10 (0.51) PARP10PARP1FABP6PARP11GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1208104-B1 TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES AGOURON PHARMA (US) 2005-01-19 — — EP disclosed
US-6548494-B1 3,4-dihydro-2H-(1,4)diazepino(6,7,1-hi)indol-1-one or 1-thione derivatives where indole C3 could also be N; use treating cancers as well as stroke, head trauma, and neurodegenerative diseases AGOURON PHARMACEUTICALS, INC. 2003-04-15 — — US disclosed
EP-1208104-A2 TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES AGOURON PHARMACEUTICALS, INC. (US) 2002-05-29 — — EP disclosed
WO-2001016136-A2 TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES AGOURON PHARMACEUTICALS, INC. (US) 2001-03-08 — — WO disclosed
Send feedback